TherapeuticsMD (TXMD) Cash from Operations (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Cash from Operations came in at 944000.0 in Q1 2026, up 35.05% YoY from 699000.0 in Q1 2025, and up 151.73% on a QoQ basis from 375000.0 in Q4 2025.
TherapeuticsMD (TXMD) Cash from Operations (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Cash from Operations data on file, last reported at 944000.0 in Q1 2026.
- Quarterly Cash from Operations rose 35.05% year-over-year to 944000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2699000.0 (up 28.65% YoY) and the FY2025 annual result came in at 2454000.0, up 109.74% from the prior year.
- Cash from Operations improved to 944000.0 in Q1 2026, from 375000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 30236000.0 in Q4 2022 to a low of 20721000.0 in Q2 2022.
- A 5-year average of 538470.59 and a median of 17000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 134.03% — and 2025, when it surged 2105.88%.
- Tracing TXMD's Cash from Operations over 5 years: stood at 30236000.0 in 2022, then slumped by 116.4% to 4960000.0 in 2023, then jumped by 100.34% to 17000.0 in 2024, then surged by 2105.88% to 375000.0 in 2025, then jumped by 151.73% to 944000.0 in 2026.
- The last three Cash from Operations figures came in at 944000.0 (Q1 2026), 375000.0 (Q4 2025), and 999000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.67 Mn | 14.48 Mn | - | 779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 779,000.00 |
| Jun 30, 2026 | 779,000.00 |
| Mar 31, 2026 | 944,000.00 |
| Mar 31, 2026 | 944,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | -229,000.00 |
| Mar 31, 2024 | -229,000.00 |